Skip Navigation

Strengthen the Evidence for Maternal and Child Health Programs

Search Results: MCHLine

Items in this list may be obtained from the sources cited. Contact information reflects the most current data about the source that has been provided to the MCH Digital Library.

Displaying records 1 through 2 (2 total).

Association of State and Territorial Health Officials. 2014. 17 alpha-hydroxyprogesterone caproate (17P). Arlington, VA: Association of State and Territorial Health Officials, 2 pp.

Annotation: This fact sheet provides information about preterm birth (PTB) rates and racial disparities in PTB in the United States, the use of 17 alpha-hydroxyprogesterone caproate (17P) to prevent PTB, and the role of state and territorial health agencies in promoting access to 17P. Contents include state examples of 17P interventions in Louisiana, North Carolina, and Ohio. The fact sheet also discusses costs, quality, and other challenges related to the availability of and access to 17P.

Contact: Association of State and Territorial Health Officials, 2231 Crystal Drive, Suite 450, Arlington, VA 22202, Telephone: (202) 371-9090 Fax: (571) 527-3189 Web Site: Available from the website.

Keywords: Access to health care, Barriers, Louisiana, North Carolina, Ohio, Pharmaceutical fees, Pregnant women, Preterm birth, Preventive medicine, State agencies

National Governors' Association, Health Policy Studies Division. 2000. States face increased expenditures for pharmaceuticals. Washington, DC: National Governors' Association, Health Policy Studies Division, 4 pp. (Issue brief)


This project is supported by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) under grant number U02MC31613, MCH Advanced Education Policy, $3.5 M. This information or content and conclusions are those of the author and should not be construed as the official position or policy of, nor should any endorsements be inferred by HRSA, HHS or the U.S. Government.